Get started

Stocksignals

APPLE (AAPL)Apple's innovation shown in iPhone 14 is not likely enough to entice consumers to stretch their budgets in the current macroeconomic environment 40% of Warren Buffett portfolio still belongs to Apple?! for most people and traders I think its a slow asset class and like Tim Apple! sorry Cook ,Warren like to play safe too Apple price showed a good reaction to 135 support and now heading to 149, for Scalpers breaking 150 resistance can be a good long opportunity and for investors AAPL still can back to 125$ levels so there is no reason to fomo
NASDAQ:AAPLLong
by moonypto
2
Intel Corporation | INTCIntel reported second quarter earnings on Thursday, showing a return to profitability after two straight quarters of losses and issuing a stronger-than-expected forecast. the stock rose 7% in extended trading. Here’s how Intel did versus Refinitiv consensus expectations for the quarter ended July 1: Earnings per share: 13 cents, adjusted, versus a loss of 3 cents expected by Refinitiv. Revenue: $12.9 billion, versus $12.13 billion expected by Refinitiv. For the third quarter, Intel expects earnings of 20 cents per share, adjusted, on revenue of $13.4 billion at the midpoint, versus analyst expectations of 16 cents per share on $13.23 billion in sales. Intel posted net income of $1.5 billion, or 35 cents per share, versus a net loss of $454 million, or a loss of 11 cents per share, in the same quarter last year. Revenue fell 15% to $12.9 billion from $15.3 billion a year ago, marking the sixth consecutive quarter of declining sales. Intel CEO Pat Gelsinger said on a call with analysts the company still sees “persistent weakness” in all segments of its business through year-end, and that server chip sales won’t recover until the fourth quarter. He also said that cloud companies were focusing more on securing graphics processors for artificial intelligence instead of Intel’s central processors. David Zinsner, Intel’s finance chief, said in a statement that part of the reason the report was stronger than expected was because of the progress the company has made toward slashing $3 billion in costs this year. Earlier this year, Intel slashed its dividend and announced plans to save $10 billion per year by 2025, including through layoffs. “We have now exited nine lines of business since Gelsinger rejoined the company, with a combined annual savings of more than $1.7 billion,” said Zinsner. Revenue in Intel’s Client Computing group, which includes the company’s laptop and desktop processor shipments, fell 12% to $6.8 billion. The overall PC market has been slumping for over a year. Intel’s server chip division, which is reported as Data Center and AI, saw sales decline 15% to $4 billion plus Intel’s Network and Edge division, which sells networking products for telecommunications, recorded a 38% decline in revenue to $1.4 billion.moreover Mobileye, a publicly traded Intel subsidiary focusing on self-driving cars, saw sales slip 1% on an annual basis to $454 million and Intel Foundry Services, the business that makes chips for other companies, reported $232 million in revenue. Intel’s gross margin was nearly 40% on an adjusted basis, topping the company’s previous forecast of 37.5%. Investors want to see gross margins expand even as the company invests heavily in manufacturing capability. In the first quarter, the company posted its largest loss ever as the PC and server markets slumped and demand declined for its central processors. Intel’s results on Thursday beat the forecast that management gave for the second quarter at the time. Intel management has said the turnaround will take time and that the company is aiming to match TSMC’s chip-manufacturing prowess by 2026, which would enable it to bid to make the most advanced mobile processors for other companies, a strategy the company calls “five nodes in four years.” Intel said on Thursday that it remained on track to hit those goals. Nvidia has had an amazing run, but any emerging technology, such as AI, which is bottlenecked by a single company will have issues in growth. Consulting firm McKinsey has pegged the AI market to be worth $1 trillion by 2030, but also that it was in an experimental and in early phases of commercial deployment. While Nvidia will likely retain its leadership in GPU hardware as applied to AI for the foreseeable future, it is likely that other hardware solutions for AI systems will also be successful as AI matures. While technologist may quibble on specifics, all major AI hardware today are based on GPU architectures, and as such I will use the terms and concepts of AI hardware and GPU architecture somewhat interchangeably. One likely candidate for AI related growth may be AMD (AMD), which has had GPU products since acquiring ATI in 2006.However, unlike Nvidia, which had a clear vision for of general-purpose GPU products (GPGPU), historically, AMD had largely kept its focus on the traditional gaming applications. AMD has developed an AI architecture called XDNA, and an AI accelerator called Alveo and announced its MI300, an integrated chip with GPU acceleration for high-performance computing and machine learning. How AMD can and may evolve in the AI may be subject of a different article. Another contender for success in the AI applications using GPU is Intel, who is the focus of this article. Intel has maintained a consistent, if low key focus on GPU hardware focused on AI applications over the last decade. Intel’s integrated HD Graphics is built into most modern processor ICs; however, these are insufficient compared to dedicated GPUs for high-end inferencing or machine learning tasks. It has 2 primary GPU architectures in production release: In 2019 Intel Corporation acquired Habana Labs, an Israel-based developer of programmable deep learning accelerators for the data center for approximately $2 billion. Habana Labs’ Gaudi AI product line from its inception focused on AI deep learning processor technologies, rather than as GPU that has been extended to AI applications. As a result, Gaudi microarchitecture was designed from the start for the acceleration of training and inferencing. In 2022 Intel announced Gaudi2 and Greco processors for AI deep learning applications, implemented in 7-nanometer (TSMC) technology and manufactured on Habana’s high-efficiency architecture. Habana Labs benchmarked Gaudi2’s training throughput performance for the ResNet-50 computer vision model and the BERT natural language processing model delivering twice the training throughput over the Nvidia high end A100-80GB GPU. So, Gaudi appears to give Intel a competitive chip for AI applications. Concurrent with the Habana Labs’ Gaudi development, Intel has internally developed the Xe GPU family, as dedicated graphics card to address high-end inferencing or machine learning tasks as well as more traditional high-end gaming. Iris® Xe GPU family consists of a series of microarchitectures, ranging from integrated/low power (Xe-LP) to enthusiast/high performance gaming (Xe-HPG), data center/AI (Xe-HP) and high-performance computing (Xe-HPC). The architecture has been commercialized in Intel® Data Center GPU Flex Series (formerly codenamed Arctic Sound) and Intel® Arc GPU cards. There is some question on Xe GPU future and evolution. Intel has shown less commitment to the traditional GPU space compared to Gaudi. Nonetheless, it does demonstrate Intel ability to design and field complex GPU products as its business requires. Intel has many other AI projects underway. The Sapphire Rapids chips implements AI specific acceleration blocks including technology called AMX (Advanced Matrix Extensions), which provides acceleration inside the CPU for efficient matrix multiplications used in on-chip inferencing and machine learning processing by speeding up data movement and compression. Intel has supporting technologies such as Optane, which while cancelled as a production line, is available for their needs of a high-performance non-volatile memory, one of the intrinsic components in any AI product. Based on the above, Intel appears to have competitive hardware solutions, however if we look at Nvidia success in AI, it is a result of a much a software and systems focus as it is the GPGPU hardware itself. Can Intel compete on that front. Ignoring for the moment that Intel has a huge software engineer (approx. 15,000) resource, it also has- access to one of the leading success stories in perhaps the most competitive AI application – self driving cars. Mobileye, who was acquired by Intel in 2017, has been an early adopter and leader, with over 20 years of experience in automotive automated driving and vision systems. As such, Mobileye has a deep resource of AI domain information that should be relevant to many applications. Mobileye has announced that it is working closely with Habana, as related divisions within Intel. While Intel is in the process of re-spinning out Mobileye as public company, Mobileye Global Inc. (MBLY), at present Intel still owns over 95% of shares, keeping it effectively an Intel division. In looking at Intel, we have a company with the history, resources, and technology to compete with Nvidia and infrastructure. They have made significant investment and commitment to the emerging AI market, in times when they have exited other profitable businesses. It should also be understood that AI related product are a small percentage of overall Intel revenues (INTC revenue are more than twice NVDA, even if NVDA has 6x its market cap), and continues to keep its primary business focus on its processor and foundry business. Hopefully for shareholders, Intel continues to push their AI technology and business efforts. Their current position is that this is strategic, but Intel is in a very fluid time and priorities may change based on business, finances, and of course the general interest and enthusiasm for AI. It is always worth noting that AI as a technical concept is mature, and appears to be cyclical, with interest in the technical community rising and falling in hype and interest once every decade or so. I remember working on AI applications, at the time labeled as expert systems in the 1980s. If we are currently at a high hype point, this may be temporary, based on near term success and disappointment in what AI does achieve. Of course, as always, “this time is different” and the building blocks of effective AI systems currently exist, where for previous iterations, it was more speculative.
NASDAQ:INTC
by moonypto
4
Intel - Reversing to the upside!Hello Traders and Investors, today I will take a look at Intel . -------- Explanation of my video analysis: On the chart of Intel there are actually two major horizontal structure levels which you have to keep an eye on. First of all there is quite strong support at the $26 level and just a couple of months ago Intel rejected this support towards the upside. Vice versa there is resistance at the $44 level, always pushing price lower. As we are speaking Intel is also retesting a minor support so there is the chance to capitalize on a short term bounce. -------- Keep your long term vision, Philip (BasicTrading)
NASDAQ:INTCLong
by basictradingtv
1
GE HealthCare | GEHCGE Healthcare aka GEHC is a renowned global medical technology, pharmaceutical diagnostics, and digital solutions company that aims to revolutionize healthcare by eliminating limits. With a diverse portfolio of innovative products, services, and solutions, GEHC empowers healthcare professionals to make informed decisions quickly and improve patient care across the entire healthcare continuum. This article delves into the key aspects of GE Healthcare, including its business segments, macro trends driving growth, management incentives, financial performance, competitors, and valuation. GE Healthcare operates in four business segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics. These segments cater to healthcare providers and researchers worldwide, offering a wide range of products and solutions that enhance clinical decision-making and patient outcomes. The company's revenue streams come from the sale of medical devices, consumable products, services, and digital solutions. By focusing on customer-driven innovation, industry-leading service capabilities, and integrated digital solutions, GEHC continually improves the performance, quality, and customer experience of its offerings. GE Healthcare benefits from several macro trends that are shaping the healthcare industry. The growing adoption of precision health, fueled by advancements in genomics, personalized medicine, and targeted therapies, presents opportunities for GEHC to develop tailored solutions. The global precision medicine market is projected to reach $278.3 billion by 2027, with a CAGR of 10.5%. Additionally, the market for genomic testing is expected to reach $30.9 billion by 2027, growing at a CAGR of 14.7%. The digitization of healthcare through AI and machine learning enables the analysis of vast amounts of patient data for more accurate diagnoses and treatment decisions. The global healthcare artificial intelligence market is predicted to reach $31.3 billion by 2025, growing at a CAGR of 41.5%. Furthermore, increasing demand for healthcare services driven by demographic trends and improving access to healthcare in emerging markets further support GEHC's growth trajectory. With personalized medicine estimated to have a market value of $3,168.0 billion by 2027, GEHC is well positioned to leverage these trends and provide innovative solutions to meet the evolving needs of the healthcare industry (Sources: Grand View Research, Fortune Business Insights, Allied Market Research, MarketsandMarkets). GEHC CEO, Peter J. Arduini, has improved incentives in place to drive the company's performance. With an amended offer letter, Arduini's base salary increased to $1,250,000, accompanied by an annual target bonus of 150% of his base salary and an annual long-term incentive grant target of $11,875,000 starting in 2023. These incentives provide a strong motivation for Arduini to lead GEHC's growth and success, enhancing shareholder value. In 2022, GEHC reported total revenue of $18.34 billion, representing a favorable increase compared to the previous year. Although the profitability declined in the final quarter, the company's operating cash flow and adjusted EBIT margin showed positive trends. GEHC guided organic revenue growth of 5% to 7% for 2023, along with higher adjusted EBIT margin and EPS ranges. The company's commitment to achieving a free cash flow conversion target of 85% or more further reinforces its positive financial outlook. GEHC faces competition from prominent players in the medical technology industry, including Philips Healthcare, Draeger, Mindray, Masimo, and Baxter. In specific segments, GEHC competes with Siemens Healthineers, Canon, Fujifilm, Carestream, Hologic, and other companies. Despite competition, GEHC's comprehensive product portfolio, customer-focused approach, and commitment to innovation position it well in the market. GE Healthcare stands out from its competitors in the healthcare sector due to its robust portfolio of cutting-edge products and data-driven solutions. The company's commitment to innovation and advanced technologies enables it to offer unique offerings that address the evolving needs of the industry. One key area where GEHC excels is precision health. Leveraging advancements in genomics, personalized medicine, and targeted therapies, GEHC develops tailored solutions that provide precise and effective treatments for patients. For example, its innovative imaging technologies, such as magnetic resonance imaging (MRI) and computed tomography (CT), enable high-resolution visualization of anatomical structures, aiding in the accurate diagnosis and monitoring of various medical conditions. Moreover, GEHC is at the forefront of the digital revolution in healthcare. By harnessing the power of artificial intelligence (AI) and machine learning, GEHC's products analyze vast amounts of patient data to deliver more accurate diagnoses and treatment decisions. For instance, its AI-powered imaging software can detect and analyze anomalies in medical images, helping clinicians detect diseases at an early stage and enhance treatment outcomes. This data-driven approach not only improves patient care but also increases operational efficiency in healthcare facilities. GEHC's commitment to delivering innovative solutions is further reflected in its diverse product offerings. The company provides a wide range of medical devices, including ultrasound systems, patient monitors, anesthesia machines, and diagnostic imaging equipment. These products are designed to meet the unique needs of healthcare providers and patients, empowering clinicians to make informed decisions and improving patient outcomes. Based on a valuation analysis using trading multiples of similar companies, GEHC's value is estimated to range from $55 billion to $81 billion. Taking the midpoint of this range, the company's estimated enterprise value (EV) is $64 billion, suggesting a potential stock price of $125. This valuation indicates a significant upside potential of at least 66% within 18 to 24 months from the current price. With its strong market position, growth opportunities, and commitment to advancing healthcare, GEHC presents an attractive investment prospect. GE Healthcare is a leading global medical technology and digital solutions company with a clear mission to transform healthcare. With its diverse portfolio of products, services, and solutions, GEHC is well-positioned to capitalize on the growing demand for precision health, digitization, and improved access to healthcare. The company's financial performance, management incentives, and competitive landscape further support its growth potential. Considering the estimated valuation, GE Healthcare's stock price has the potential to increase significantly in the next 1.5 to 2 years, offering investors an opportunity for substantial returns.
NASDAQ:GEHCLong
by moonypto
COINBASE Can catapult above $300 any time.Coinbase Global (COIN) has been trading within a long-term Channel Up pattern since the October 27 2023 bottom. Its long-term Support level is the 4H MA200 (orange trend-line) which was most recently tested on May 14 2024 and held. Just like the February 07 (near) test, this is technically the latest Higher Low of the Channel Up. The break-out above the Falling Wedge that followed, similar to the February bottom, has found Support on the 4H MA50 (blue trend-line), which held even during Friday's dramatic pull-back. With the Sine Waves accurately depicting COIN's all recent bottoms (Higher Lows) and tops (Higher Highs), they clearly show that we are past the latest bottom and have already started the new Bullish Leg to a Higher High. The previous one was priced just above the 1.786 Fibonacci extension level. As a result, we remain bullish on this stock, setting a new price Target at $380.00 (Fib 1.786), which can be achieved by mid-July. ------------------------------------------------------------------------------- ** Please LIKE 👍, FOLLOW ✅, SHARE 🙌 and COMMENT ✍ if you enjoy this idea! Also share your ideas and charts in the comments section below! This is best way to keep it relevant, support us, keep the content here free and allow the idea to reach as many people as possible. ** ------------------------------------------------------------------------------- 💸💸💸💸💸💸 👇 👇 👇 👇 👇 👇
NASDAQ:COINLong
by TradingShot
GAMESTOP Will the meme stock have another gap up tomorrow?GameStop Corporation (GME) had a massive +75% opening today, product of 'Roaring Kitty' latest news, but corrected from $40 to sub $30 intra day. We saw a similar pattern during GME's previous rally on May 13, with a 1st Gap Up that was followed by a 2nd that eventually formed the 64.90 Resistance. Both sequences started off with a Higher Lows rise and identical 1D RSI patterns. It appears we are currently on Gap Up 1 and the late session consolidation may give way tomorrow to an equally impressive Gap up to test 64.90. Of course never forget with such kind of stocks and high importance after of pre-market news can drastically alter the technicals. ------------------------------------------------------------------------------- ** Please LIKE 👍, FOLLOW ✅, SHARE 🙌 and COMMENT ✍ if you enjoy this idea! Also share your ideas and charts in the comments section below! This is best way to keep it relevant, support us, keep the content here free and allow the idea to reach as many people as possible. ** ------------------------------------------------------------------------------- 💸💸💸💸💸💸 👇 👇 👇 👇 👇 👇
NYSE:GMELong
by TradingShot
1
Spy continues to near its target of 570 before U.S. electionsWith the dollar trending down and the VIX at low levels, we can then continue to expect the U.S. stock market to continue to rise. And, in fact, that is what we are witnessing as we close in on the blow-off top target of the Elliot Wave theory that has resonated with my instincts for these last 2 and a half years. We are currently in wave 5 and on our way to the target I have set of SPY 570-600. There is still time and I believe we will easily get there before U.S. election shenanigans begin to unfold (see my post on the VIX). Once you start to catch wind of anomalous election news events here in the U.S., know that we are near our top. For me, it will be time to pull out.
AMEX:SPYLong
by stewdamus
NIFTY 660+ Points GainAfter a massive week of 660+ points gain, NIFTY has given a SHORT opportunity yesterday. Days of volatility, guys! BIG money. Everybody is talking about the co-relation of election results. And why not, market being driven by fundamentals in full power and josh. A big move is still pending, I dont know if thats gonna happen on Monday 3rd June, 4th June or 5th June. There is a possibility of big gap-ups and gap-downs on these days, specifically. So, BTST traders, you better watch out and be careful. Risk management is key. Also, position sizing needs to be watched. You would not want to go in big with a hope to capture big move, only to witness a rude reversal. NO POSITION IS ALSO A POSITION! So, be careful, and enjoy the fireworks, gonna start any time now.
NSE:NIFTY
by ProfitsNinja
ROCKET LAB Bullish break-out imminent.Rocket Lab USA (RKLB) has completed a Bull Flag pattern (green Channel), trading right below the 1D MA200 (orange trend-line), which has been its long-term Resistance since January 24 2024. Based on its 2-year Cyclical pattern, the stock should surge aggressively if it breaks above the 1D MA200. The 1D RSI is posting the exact same formation it had during the break-outs of May 2023 and July 2022. All formed after strong rebounds within the Support Zone. In any case, our medium-term Target $5.50, which will be a test of the Lower Highs trend-line, similar to June 07 2023. ------------------------------------------------------------------------------- ** Please LIKE 👍, FOLLOW ✅, SHARE 🙌 and COMMENT ✍ if you enjoy this idea! Also share your ideas and charts in the comments section below! This is best way to keep it relevant, support us, keep the content here free and allow the idea to reach as many people as possible. ** ------------------------------------------------------------------------------- 💸💸💸💸💸💸 👇 👇 👇 👇 👇 👇
NASDAQ:RKLBLong
by TradingShot
Colgate can shine your portfolio and Teeth. Colgate-Palmolive (India) Limited is an MNC India's leading provider of scientifically proven oral care products. The range includes toothpastes, toothpowder, toothbrushes and mouthwashes under the 'Colgate' brand, as well as a specialized range of dental therapies under the banner of Colgate Oral Pharmaceuticals. The Company is engaged in manufacturing/ trading of toothpaste, tooth powder, toothbrush, mouthwash and personal care products. It also provides a range of personal care products under the `Palmolive' brand name. The positive aspects of the company are Company with No Debt, Mutual Funds Increased Shareholding in Past Month, Company with Zero Promoter Pledge and MFs increased their shareholding last quarter. The Negative aspects of the company are High P.E. Ratio=55.5, RSI indicating price weakness and Recent Broker Downgrades in Reco or Target Price. Entry can be taken after closing above 2709. Targets in the stock will be 2735, 2765 and 2827. The long-term target in the stock will be 2877, 2920 and 2961. Stop loss in the stock should be maintained at Closing below 2642. The above information is provided for educational purpose, analysis and paper trading only. Please don't treat this as a buy or sell recommendation for the stock. We do not guarantee any success in highly volatile market or otherwise. Stock market investment is subject to market risks which include global and regional risks. We will not be responsible for any Profit or loss that may occur due to any financial decision taken based on any data provided in this message.
NSE:COLPALLong
by Happy_Candles_Investment
Aarti Drugs giving signs of pennant Breakout. Aarti Drugs Limited (ADL) is a prominent manufacturer of APIs, Pharma Intermediates, and Specialty Chemicals. ADL engages in the development, manufacture and market of pharmaceutical products. The firm operates through the Out of India, and India geographical segments. Aarti Drugs Limited (ADL) CMP is 495.70. The positive aspects of the company are Company with Low Debt, Growth in Quarterly Net Profit with increasing Profit Margin, Company with Zero Promoter Pledge, FII / FPI or Institutions increasing their shareholding, and Mutual Funds Increased Shareholding. The Negative aspects of the company are Decline in Quarterly Net Profit, MFs decreased their shareholding last quarter and Promoter decreasing their shareholding. Entry can be taken after closing above 503 Targets in the stock will be 519 and 531. The long-term target in the stock will be 549 and 568. Stop loss in the stock should be maintained at Closing below 456. The above information is provided for educational purpose, analysis and paper trading only. Please don't treat this as a buy or sell recommendation for the stock. We do not guarantee any success in highly volatile market or otherwise. Stock market investment is subject to market risks which include global and regional risks. We will not be responsible for any Profit or loss that may occur due to any financial decision taken based on any data provided in this message.
NSE:AARTIDRUGSLong
by Happy_Candles_Investment
NETFLIX Bullish break-out eyeing $725.00Netflix (NFLX) has established trading above the 1D MA50 (blue trend-line), turning it into a Support following the rebound since May 01. With the long-term pattern since June 14 2022 being a Channel Up, similar bullish break-outs above the 1D MA50 (blue circles) have been the start of Bullish Legs. Even the 1D RSI has been very consistent at identifying bottoms. The last two Bullish Legs topped after the price hit the 1.786 Fibonacci extension level. As a result, we remain bullish on NFLX, targeting $725.0 (the 1.786 Fibonacci). Flashback to our previous idea: ------------------------------------------------------------------------------- ** Please LIKE 👍, FOLLOW ✅, SHARE 🙌 and COMMENT ✍ if you enjoy this idea! Also share your ideas and charts in the comments section below! This is best way to keep it relevant, support us, keep the content here free and allow the idea to reach as many people as possible. ** ------------------------------------------------------------------------------- 💸💸💸💸💸💸 👇 👇 👇 👇 👇 👇
NASDAQ:NFLXLong
by TradingShot
1
Emaar is now in a strong uptrendhello dear investors I think inchallah, Emaar will continue it uptrend until 1st target=12.50 2d target=19. Always think technically with ease: it will respect the corridor if breakout accure then you will unusually see highest levels. Just keep buyning and not sell untill breakdown this corridor. Remember that i am not having a cristal ball predicting markets movement but I try to be more rationnal . Good luck NB: if you see that i said something usefull ecncourage me in order to post more and more
DFM:EMAARLong
by HASSOUNI-trading
3
BROADCOM accumulating. Last opportunity to buy on this pull-backBroadcom Inc. (AVGO) has been trading within a long-term Channel Up since the October 13 2022 market bottom. The stock is now within the new Accumulation Phase that is being supported by the 1D MA100 (green trend-line). Based on the previous Accumulation Phase, we should get one (or two max) more pull-back towards the 1D MA100, before the price breaks upwards aggressively towards the Channel's top (Higher Highs trend-line). Last time the ultimate buy signal was when the 1D RSI made a Double Bottom. Our Target is $1800, which will be on the 3.0 Fibonacci extension, similar to the December 15 2023 High. ------------------------------------------------------------------------------- ** Please LIKE 👍, FOLLOW ✅, SHARE 🙌 and COMMENT ✍ if you enjoy this idea! Also share your ideas and charts in the comments section below! This is best way to keep it relevant, support us, keep the content here free and allow the idea to reach as many people as possible. ** ------------------------------------------------------------------------------- 💸💸💸💸💸💸 👇 👇 👇 👇 👇 👇
NASDAQ:AVGOLong
by TradingShot
BABA: Set for a Bullish Reversal, Potential Gains Exceed 50%?Hi Realistic Traders, let's delve into the technical analysis of NYSE:BABA ! On the weekly chart, BABA is making some exciting moves! It's broken out of a falling wedge pattern, forming a bullish candlestick with a long wick right on the EMA 34 line. But what really caught our eye? The significant volume spike, more than double the average. Now, why does this matter? Well, it's a clear sign of increased buying interest and strong market conviction behind the price movement. And wait, there's more good news: the MACD indicator is showing a bullish divergence, hinting at a potential reversal. So, what's the forecast? We're looking at a potential upward swing to close the gap near our first target at $117.89. After that, we might see a slight dip to the yellow zone before it continues its rally towards our second target at $165. It is essential to note that the analysis will no longer hold validity once the target/support area is reached. Disclaimer: "Please note that this analysis is solely for educational purposes and should not be considered a recommendation to take a long or short position on Alibaba Group Holdings Ltd." Please support the channel by engaging with the content, using the rocket button, and sharing your opinions in the comments below
NYSE:BABALong
by financialfreedomgoals101
8
BDL / Bharat Dynamics 35%+ in 1 week! Crazy ReturnsEverybody loves momentum. Why not? Momentum is the best friend of every trader. I always wanted to find and catch the beginning of a confirmed trend. It's unbelievable it is happening in real life. Education and skills acquisition is the key to continued growth in any field. This especially holds true in the highly risky terrain called Trading. A lot of stocks are in superb momentum and I am ready to catch them. God bless you and happy trading.
NSE:BDLLong
by ProfitsNinja
KARURVYSYA 87%+ Gain in 1 YearKARURVYSYA has been in my bag from a year now. Never thought this would touch 80%++ in gains. I had sold 50% of it at 150 price level and held the remaining. I sold 25% of the remaining this morning and keeping the remaining 25% for some more gain, especially for the week after the election results. We are for sure going to see some crazy spikes / volatility. Anybody holding KARURVYSYA? Share your story in the comments. God bless you and happy trading.
NSE:KARURVYSYALong
by ProfitsNinja
RIVIAN Accumulation before mega rally.Last month (April 18, see chart below), we called for a short-term buy on Rivian Automotive (RIVN) but expected one more pull-back before the absolute bottom: Since however the price broke above the 1D MA50 (blue trend-line) and closed a 1D candle above it too, we have to revise it and we consider April's low to be the bottom (Lower Lows trend-line) of the 1.5 year Channel Down pattern. As a result, we expect a short-term Accumulation Phase, similar to May - June 2023, before an aggressive rally towards the top (Lower Highs trend-line) of the pattern. Our target is $17.00 (just below the 0.618 Fibonacci retracement level). ------------------------------------------------------------------------------- ** Please LIKE 👍, FOLLOW ✅, SHARE 🙌 and COMMENT ✍ if you enjoy this idea! Also share your ideas and charts in the comments section below! This is best way to keep it relevant, support us, keep the content here free and allow the idea to reach as many people as possible. ** ------------------------------------------------------------------------------- 💸💸💸💸💸💸 👇 👇 👇 👇 👇 👇
NASDAQ:RIVNLong
by TradingShot
4